Blog

Mydecine Announces Conditional Approval of CSE Listing

Aug 31 • 2 min read

Mydecine Innovations Group Inc. (NEO:MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), is pleased to announce that it has made an application and received conditional approval to list its common shares on the Canadian Securities Exchange (the “CSE”) subject to fulfilling customary CSE requirements. The Company anticipates that trading will commence immediately upon receipt…

Controversial Departure: Decriminalize Nature President Steps Down Amidst Strong Reactions

Aug 30 • 6 min read

One of the most controversial figures in the psychedelic space has made a move. No one knows what to think of it, but everyone has something to say. Decriminalize Nature— one of the most influential organizations in psychedelic policy change— took to Instagram this past weekend to announce that its co-founder, Carlos Plazola, had resigned…

Oscillate Interim Loss Widens Amid Increased Investment Loss

Aug 30 • 1 min read

Oscillate PLC – investor in companies in medical psychedelics industry – Publishes interim results a day after it reported that shareholders at the annual general meeting rejected placing company into members voluntary liquidation. Loss in the six months to May 31 widens 46% to GBP508,310 from GBP348,033 a year prior. Loss on investments at fair…

COMPASS Pathways To Participate in Upcoming September Investor Conferences

Aug 30 • 3 min read

COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in the following investor conferences: Live audio webcasts of the fireside chats at the HC Wainwright and Cantor conferences will be accessible from the “Events” page of the “Investors” section…

PSYC Enters Strategic Partnership with Target Media to Help Accelerate Audience and Revenue Growth Opportunities

Aug 29 • 5 min read

PSYC Corporation (OTC Pink Market: PSYC) (“PSYC”, “PSYC Corp” or the “Company”), parent company to Spotlight Media Corporation (“SMC” or the “wholly owned subsidiary”), a multimedia leader for all things psychedelics including the emerging medicinal psychedelics market sector is pleased to announce the formation of a global strategic partnership between the Company and Target Media that will combine PSYC’s…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560